再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09688 再鼎医药

休市中 01-09 16:08:35

14.510

-0.250

-1.69%

最高14.680	最低14.320	成交量1,352万
今开14.680	昨收14.760	日振幅2.44%
总市值162.51亿	流通市值162.51亿	总股本11.20亿
成交额1.96亿	换手率1.21%	流通股本11.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09688","market":"HK","secType":"STK","nameCN":"再鼎医药","latestPrice":14.51,"timestamp":1767946115008,"preClose":14.76,"halted":0,"volume":13515890,"delay":0,"floatShares":1120000000,"shares":1120000000,"eps":-2.0254983123250936,"marketStatus":"休市中","change":-0.25,"latestTime":"01-09 16:08:35","open":14.68,"high":14.68,"low":14.32,"amount":196024594,"amplitude":0.02439,"askPrice":14.51,"askSize":10600,"bidPrice":14.49,"bidSize":3100,"shortable":3,"etf":0,"ttmEps":-1.4989281510410577,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768181400000},"marketStatusCode":7,"adr":0,"listingDate":1601222400000,"exchange":"SEHK","adjPreClose":14.76,"openAndCloseTimeList":[[1767922200000,1767931200000],[1767934800000,1767945600000]],"volumeRatio":1.5311333395131592,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09688","defaultTab":"news","newsList":[{"id":"2602377727","title":"每日卖空追踪 | 再鼎医药 01月09日卖空量成交214万股，卖空比例为15.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602377727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602377727?lang=zh_cn&edition=full","pubTime":"2026-01-09 16:30","pubTimestamp":1767947441,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间01月09日，跌1.69%，卖空量成交214万股，较上一交易日增加5.87%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109163959a4af866d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109163959a4af866d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","LU2488822045.USD","BK1161","09688","BK1588"],"gpt_icon":0},{"id":"2602377082","title":"再鼎医药01月09日主力净流出1381.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2602377082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602377082?lang=zh_cn&edition=full","pubTime":"2026-01-09 16:15","pubTimestamp":1767946554,"startTime":"0","endTime":"0","summary":"01月09日, 再鼎医药股价跌1.69%，报收14.51元，成交金额2.0亿元，换手率1.21%，振幅2.44%，量比1.53。再鼎医药今日主力资金净流出1381.6万元，上一交易日主力净流入1020.6万元。该股近5个交易日上涨6.55%，主力资金累计净流入1571.7万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出506.5万元，其中净流出天数为7日。该股主力净额占比0.09%，港股市场排名2664/2716。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109162236a4af71e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109162236a4af71e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1588","LU2488822045.USD","09688","BK1574"],"gpt_icon":0},{"id":"2602884312","title":"【券商聚焦】华泰证券：开年以来的流动性修复有望提振创新药板块β","url":"https://stock-news.laohu8.com/highlight/detail?id=2602884312","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602884312?lang=zh_cn&edition=full","pubTime":"2026-01-09 08:58","pubTimestamp":1767920334,"startTime":"0","endTime":"0","summary":"金吾财讯 | 华泰证券表示，自9月港股创新药年内新高以来，港股创新药指数截止到年底回调24%，而同期美股生物科技指数XBI涨幅29%，NBI指数涨幅18%。XBI自4月底部反弹超过100%，大型MNC普遍自底部反弹30~50%，礼来市值首次突破万亿美金。步入新的一年，港股创新药迎来开门红。随着流动性修复及对外BD持续，以及JPM峰会、年报周期的BD旺季和数据披露高峰的到来，该机构认为开年以来的流动性修复有望提振创新药板块β，上涨趋势有望持续。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MjAwMmJhMzhlMzU2ODgyNzA0NzY4MTcyNA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1972900","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0561508036.HKD","LU0315179316.USD","159992","IE0008369823.USD","02269","06978","BK1500","LU0043850808.USD","02142","601688","09995","BK1141","LU1960683339.HKD","01877","LU0516423174.USD","01177","06160","LU0516422952.EUR","LU1152091168.USD","09926","LU2097828474.EUR","LU1934453819.USD","LU2097828805.USD","LU1226287792.SGD","IE00B5MMRT66.SGD","LU1807302812.USD","LU0307460666.USD","LU0516422440.USD","01093","LU1064131003.USD","BK1589","01801","LU1328277881.USD","02616","BK0012","LU0067412154.USD","LU0502904849.HKD","06185","LU0501845795.SGD","BK0183","LU0417516571.SGD","LU2148510915.USD","09688","LU2476274720.SGD","LU1993786604.SGD","LU1242518857.USD","LU3063872942.SGD","LU0039217434.USD","LU0588546209.SGD","LU1979443071.USD"],"gpt_icon":0},{"id":"2602639763","title":"赛生药业获得再鼎医药“瑞普替尼”中国大陆独家推广权","url":"https://stock-news.laohu8.com/highlight/detail?id=2602639763","media":"丁香园 Insight 数据库","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602639763?lang=zh_cn&edition=full","pubTime":"2026-01-08 11:52","pubTimestamp":1767844349,"startTime":"0","endTime":"0","summary":"1 月 8 日消息，赛生药业宣布已于近日与再鼎医药达成合作，获得新一代酪氨酸激酶抑制剂 瑞普替尼在中国大陆的独家推广权，双方将携手推进该创新药物在中国市场的商业化。2020 年 7 月，再鼎医药与 Turning Point达成一项1.76 亿美元的独家授权协议，获得瑞普替尼在大中华区的独家开发及商业化权。2024 年 5 月，瑞普替尼获中国 NMPA 批准上市，用于治疗ROS1 阳性的局部晚期或转移性非小细胞肺癌成人患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108140004a4aab112&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108140004a4aab112&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09688","BK1191","BK1588","BK1574","LU2488822045.USD"],"gpt_icon":1},{"id":"1162544881","title":"再鼎医药（09688）更新2025年12月股份变动月报表 股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1162544881","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162544881?lang=zh_cn&edition=full","pubTime":"2026-01-07 17:31","pubTimestamp":1767778275,"startTime":"0","endTime":"0","summary":"再鼎医药有限公司于2026年1月7日披露截至2025年12月31日的股份变动月报表。公告显示，公司期内法定股本及已发行股份总数均保持不变。激励计划方面，2025年12月涉及部分股权激励计划的期权行使及限制性股票单位归属均通过现有已发行股份兑现，并未导致已发行股份总数增加；少量无归属期权及RSU则宣告失效，对当月股本无任何影响。公司指出，当月行使期权所获得款项约6,510.24美元。公告由公司董事杜瑩签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09688"],"gpt_icon":0},{"id":"2601767758","title":"每日卖空追踪 | 再鼎医药 01月07日卖空量成交232.99万股，卖空比例为18.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601767758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601767758?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:30","pubTimestamp":1767774643,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间01月07日，涨2.78%，卖空量成交232.99万股，较上一交易日增加14.66%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163644a6fde155&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163644a6fde155&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","LU2488822045.USD","09688","BK1161","BK1588"],"gpt_icon":0},{"id":"2601987676","title":"再鼎医药01月07日获主力加仓757.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601987676","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601987676?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:15","pubTimestamp":1767773742,"startTime":"0","endTime":"0","summary":"01月07日, 再鼎医药股价涨2.78%，报收14.80元，成交金额1.9亿元，换手率1.15%，振幅3.40%，量比1.67。再鼎医药今日主力资金净流入757.8万元，连续4日净流入，上一交易日主力净流入328.2万元。近一年数据显示，该股主力连续4日净流入后，次日上涨概率为50.00%，平均涨幅为4.67%。该股近5个交易日上涨7.25%，主力资金累计净流入1228.7万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入299.2万元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107161927a6fdcb25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107161927a6fdcb25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","BK1574","BK1588","BK1161","LU2488822045.USD"],"gpt_icon":0},{"id":"2601841928","title":"再鼎医药01月06日获主力加仓328.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601841928","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601841928?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:15","pubTimestamp":1767687334,"startTime":"0","endTime":"0","summary":"01月06日, 再鼎医药股价涨1.62%，报收14.40元，成交金额1.3亿元，换手率0.79%，振幅2.89%，量比0.92。再鼎医药今日主力资金净流入328.2万元，连续3日净流入，上一交易日主力净流入846.7万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为68.75%，平均涨幅为3.37%。该股近5个交易日上涨4.56%，主力资金累计净流出3286.8万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出213.4万元，其中净流出天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106161807a6f97115&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106161807a6f97115&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1588","BK1161","09688","BK1574"],"gpt_icon":0},{"id":"2601830324","title":"不限癌种！再鼎医药“瑞普替尼”新适应症国内获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2601830324","media":"丁香园 Insight 数据库","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601830324?lang=zh_cn&edition=full","pubTime":"2026-01-05 18:04","pubTimestamp":1767607477,"startTime":"0","endTime":"0","summary":"作为新一代 ROS1 和 NTRK TKI，瑞普替尼的独特设计可用于改善包括脑部在内的获益持久性。瑞普替尼NTRK 阳性实体瘤适应症在美国的获批是基于 I/II 期 TRIDENT-1 研究的积极结果，该研究旨在评估瑞普替尼在 NTRK 阳性成人实体瘤患者中的疗效。截图来源：Insight 数据库在国内，瑞普替尼于 2024 年 5 月首次获得 NMPA 批准上市，用于局部晚期或转移性 ROS1 阳性 NSCLC成人患者。本次是瑞普替尼在国内获批的第 2 项适应症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105184353a49ea968&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105184353a49ea968&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","BK1588","LU2488822045.USD","BK1574","BK1161"],"gpt_icon":0},{"id":"2601830315","title":"每日卖空追踪 | 再鼎医药 01月05日卖空量成交89.69万股，卖空比例为8.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601830315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601830315?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:30","pubTimestamp":1767601841,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间01月05日，涨4.34%，卖空量成交89.69万股，较上一交易日增加45.84%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163831a49e2cc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105163831a49e2cc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","09688","BK1588","LU2488822045.USD","BK1161"],"gpt_icon":0},{"id":"2601830376","title":"再鼎医药01月05日获主力加仓846.7万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601830376","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601830376?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:15","pubTimestamp":1767600923,"startTime":"0","endTime":"0","summary":"01月05日, 再鼎医药股价涨4.34%，报收14.17元，成交金额1.5亿元，换手率0.93%，振幅6.85%，量比0.80。再鼎医药今日主力资金净流入846.7万元，上一交易日主力净流入174.9万元。该股近5个交易日下跌2.14%，主力资金累计净流出3465.0万元；近20日主力资金累计净流出535.3万元，其中净流出天数为6日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105161701a49e12de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105161701a49e12de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09688","LU2488822045.USD","BK1588"],"gpt_icon":0},{"id":"1100237131","title":"港股异动 | 创新药概念股走高，歌礼制药涨近10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1100237131","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100237131?lang=zh_cn&edition=full","pubTime":"2026-01-05 10:19","pubTimestamp":1767579594,"startTime":"0","endTime":"0","summary":"1月5日，港股创新药概念股盘中走高，$歌礼制药-B(01672)$涨近10%，$信达生物(01801)$、$云顶新耀(01952)$、$科伦博泰生物-B(06990)$涨超5%，$百济神州(06160)$、$再鼎医药(09688)$、$三生制药(01530)$涨超4%，$石药集团(01093)$、$药明康德(02359)$涨超3%。歌礼制药-B","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f1a65319f224684be7c4d1ad3324a2f2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","06160","09688","02359"],"gpt_icon":0},{"id":"2595476307","title":"每日卖空追踪 | 再鼎医药 12月30日卖空量成交44.21万股，卖空比例为5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595476307","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595476307?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:30","pubTimestamp":1767083440,"startTime":"0","endTime":"0","summary":"再鼎医药北京时间12月30日，跌0.14%，卖空量成交44.21万股，较上一交易日减少71.4%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163638a4898170&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230163638a4898170&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","BK1588","BK1574","BK1161","LU2488822045.USD"],"gpt_icon":0},{"id":"2595747691","title":"再鼎医药12月30日遭主力抛售878.9万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595747691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595747691?lang=zh_cn&edition=full","pubTime":"2025-12-30 16:16","pubTimestamp":1767082562,"startTime":"0","endTime":"0","summary":"12月30日, 再鼎医药股价跌0.14%，报收13.80元，成交金额1.2亿元，换手率0.77%，振幅1.74%，量比0.59。该股近5个交易日下跌1.52%，主力资金累计净流出5040.1万元；近20日主力资金累计净流出1176.0万元，其中净流出天数为6日。|12月30日主力加仓幅度排名||#|股票简称|主力净额占比|#|信能低碳|6.92%|#|瀛晟科学股权|2.03%|#|帝国科技集团|1.96%|#|...|...|#2611|再鼎医药|-0.06%|（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230162323a4897287&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251230162323a4897287&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","09688","BK1574","LU2488822045.USD","BK1161"],"gpt_icon":0},{"id":"2594531452","title":"绿叶，十年27亿！","url":"https://stock-news.laohu8.com/highlight/detail?id=2594531452","media":"药通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594531452?lang=zh_cn&edition=full","pubTime":"2025-12-25 17:37","pubTimestamp":1766655464,"startTime":"0","endTime":"0","summary":"就在昨日，绿叶宣布与恩华药业签署合作协议，授予后者三款抗精神病药长效针剂产品在中国大陆地区的独家商业化权利，合作期限至2035年底。值得注意的是，根据协议，恩华需一次性支付2000万美元不可退还的授权对价，并承诺在2026年至2035年的十年间，完成合作产品总计不低于27亿元人民币的含税销售额。2020年强生的利培酮微球注册证到期未续退出中国，2021年，绿叶的改良利培酮微球瑞可妥上市，稳坐了四年独家，2024年瑞可妥院内销售额达到四千万。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225180818a47727f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225180818a47727f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","LU2488822045.USD","BK1606","09688","BK1574","BK1588","BK1161","BK1583","02186"],"gpt_icon":0},{"id":"2593213634","title":"审批进度加快，年末多款创新药集中获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2593213634","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593213634?lang=zh_cn&edition=full","pubTime":"2025-12-24 13:56","pubTimestamp":1766555761,"startTime":"0","endTime":"0","summary":"江海证券研报认为，此次“四连发”不仅是审评审批效率的体现，更标志着中国创新药研发成果迎来一轮密集的上市收获期。2024年，我国有48个创新药获批上市。此前的12月7日，国家药监局党组成员、副局长杨胜对外表示，今年以来，中国批准上市的创新药，截至当天，达到69个，已经超过了去年全年，再次创造了历史新高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224135811953b98c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224135811953b98c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09969","06978","09688","LU2488822045.USD","BK1588"],"gpt_icon":0},{"id":"1192354904","title":"异动解读 | 再鼎医药盘中大涨5.06%，抗精神分裂症新药凯捷乐在华获批","url":"https://stock-news.laohu8.com/highlight/detail?id=1192354904","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192354904?lang=zh_cn&edition=full","pubTime":"2025-12-24 09:54","pubTimestamp":1766541287,"startTime":"0","endTime":"0","summary":"再鼎医药今日盘中股价大涨5.06%，引发市场关注。消息面上，中国国家药品监督管理局于12月23日批准了再鼎医药的呫诺美林曲司氯铵胶囊(凯捷乐)的新药上市申请，用于治疗成人精神分裂症。这是70余年来首个获批的具有全新作用机制的精神分裂症疗法，标志着该疾病治疗领域的重大突破。中国约有800万精神分裂症患者，该药物的获批有望满足巨大的未满足医疗需求，为再鼎医药带来新的增长动力。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["09688"],"gpt_icon":0},{"id":"2593421346","title":"再鼎医药盘中异动 大幅拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593421346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593421346?lang=zh_cn&edition=full","pubTime":"2025-12-24 09:53","pubTimestamp":1766541196,"startTime":"0","endTime":"0","summary":"2025年12月24日早盘09时53分，再鼎医药股票出现波动，股价大幅上涨5.06%。截至发稿，该股报14.320港元/股，成交量560.88万股，换手率0.50%，振幅4.40%。再鼎医药股票所在的生物技术行业中，整体涨幅为0.95%。其相关个股中，东曜药业-B、百奥赛图-B、泰格医药涨幅较大，振幅较大的相关个股有东曜药业-B、百奥赛图-B、药捷安康-B，振幅分别为31.43%、19.16%、8.68%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224095316a6c81a6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224095316a6c81a6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","LU2488822045.USD","09688","BK1588"],"gpt_icon":0},{"id":"2593447132","title":"港股异动 | 再鼎医药(09688)早盘涨超4% 重磅抗精神分裂症新药凯捷乐在中国获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2593447132","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593447132?lang=zh_cn&edition=full","pubTime":"2025-12-24 09:44","pubTimestamp":1766540643,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，再鼎医药早盘涨超4%，截至发稿，涨3.45%，报14.1港元，成交额5919.14万港元。消息面上，12月23日，再鼎医药宣布，中国国家药品监督管理局已批准呫诺美林曲司氯铵胶囊（凯捷乐）的新药上市申请，用于治疗成人精神分裂症。这是70余年来首个获批的具有全新作用机制的精神分裂症疗法，为精神分裂症治疗带来了根本性突破。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385285.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 再鼎医药(09688)早盘涨超4% 重磅抗精神分裂症新药凯捷乐在中国获批上市","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK4548","BK4588","BK4585","LU2488822045.USD","BK4531","BK1588","BK1161","BK4526","ZLAB","09688","BK4139"],"gpt_icon":0},{"id":"2593444378","title":"智通港股通占比异动统计|12月24日","url":"https://stock-news.laohu8.com/highlight/detail?id=2593444378","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593444378?lang=zh_cn&edition=full","pubTime":"2025-12-24 08:36","pubTimestamp":1766536569,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，根据2025年12月23日披露数据，狮腾控股、均胜电子、东方电气港股通持股占比增加值最大，分别增加2.12%、1.44%、1.17%；佑驾创新、山东墨龙、浙江世宝港股通持股占比减少值最大，分别减少-1.16%、-1.09%、-0.72%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00175","02727","02160","02603","09696","02465","01880","09927","01341","01635","02431","00699","01798","06166","01952","00187","01057","02273","00119","00552","00358","00568","02498","02643","00638","02579","03678","02570","03323","09688","01072","00839","00553","02587","01896","06127","06693","01709","01138","01357","03347","02648","01071","02865","02562","03033","00038","01528"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.zailaboratory.com","stockEarnings":[{"period":"1week","weight":0.0685},{"period":"1month","weight":0.0175},{"period":"3month","weight":-0.4283},{"period":"6month","weight":-0.4462},{"period":"1year","weight":-0.2521},{"period":"ytd","weight":0.063}],"compareEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":0.0271},{"period":"3month","weight":-0.0022},{"period":"6month","weight":0.0867},{"period":"1year","weight":0.3633},{"period":"ytd","weight":0.0235}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"再鼎医药有限公司是一家主要从事生物制药的控股公司。该公司致力于通过产品的发现、开发和商业化解决肿瘤、自身免疫疾病、感染性疾病和中枢神经系统疾病领域未被满足的医疗需求。该公司拥有从发现阶段到临床项目后期的一系列专利候选药物。其中包括“则乐”、“OPTUNE”、“擎乐”、“纽再乐”及“卫伟迦”等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.000505},{"month":2,"riseRate":0.6,"avgChangeRate":0.053227},{"month":3,"riseRate":0.2,"avgChangeRate":-0.100669},{"month":4,"riseRate":0.6,"avgChangeRate":0.032813},{"month":5,"riseRate":0.4,"avgChangeRate":-0.024133},{"month":6,"riseRate":0.4,"avgChangeRate":-0.013792},{"month":7,"riseRate":0.8,"avgChangeRate":0.065752},{"month":8,"riseRate":0.6,"avgChangeRate":-0.021717},{"month":9,"riseRate":0.4,"avgChangeRate":-0.054178},{"month":10,"riseRate":0.5,"avgChangeRate":-0.051338},{"month":11,"riseRate":0.5,"avgChangeRate":0.047251},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.024481}],"exchange":"SEHK","name":"再鼎医药","nameEN":"ZAI LAB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供再鼎医药(09688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"再鼎医药,09688,再鼎医药股票,再鼎医药股票老虎,再鼎医药股票老虎国际,再鼎医药行情,再鼎医药股票行情,再鼎医药股价,再鼎医药股市,再鼎医药股票价格,再鼎医药股票交易,再鼎医药股票购买,再鼎医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"再鼎医药(09688)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供再鼎医药(09688)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}